studyrandomized trial
expert reaction to abstract of Phase 3 INTerpath-001 trial results of an individualised mRNA vaccine for resected stage IIB-IV melanoma, due to be presented at ESMO
Science Media Centre · 19d ago
Heather Shaw
Medicine & Biotech · covered by 1 outlet this week · tracked since 2026-11-07
Press: 1 specialist outlet-days